Royal Bank Of Canada Eargo, Inc. Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.73 $3,993 - $5,948	-8,149 Reduced 97.77%	186 $0
Q3 2022 Nov 14, 2022	BUY	$0.7 - $3.0 $2,200 - $9,429	3,143 Added 60.54%	8,335 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $5.6 $1,383 - $10,332	-1,845 Reduced 26.22%	5,192 $4,000
Q1 2022 May 16, 2022	SELL	$3.3 - $7.28 $16,879 - $37,237	-5,115 Reduced 42.09%	7,037 $37,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $44,040 - $97,750	9,574 Added 371.37%	12,152 $62,000
Q3 2021 Nov 15, 2021	SELL	$6.59 - $38.71 $290,711 - $1.71 Million	-44,114 Reduced 94.48%	2,578 $17,000
Q2 2021 Aug 16, 2021	BUY	$32.1 - $57.78 $1.5 Million - $2.7 Million	46,692 New	46,692 $1.86 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.